Four Peaks Healthcare Associates

01/18/2026

An Australian MECFS study looked at multiple areas of interest and "integrated energy metabolism, blood proteins, and immune cell findings together to determine how the different systems in the body are interacting with each other." Due to the complexities of the areas studied and MECFS's multifactorial systems AI is being used to help filter through the information.

Geoff’s Narration The GIST   ME/CFS studies keep getting more comprehensive and more complex. Take this nice robust recent Australian study, “Mapping the complexity of ME/CFS: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction“, which integrated energy m...

01/02/2026

Read the news from the Open Medicine Foundation's five research centers around the world (US, Canada, Australia, Sweden). The directors of the research centers make up a diverse group of scientists across multiple specialties that frequently speak with each other of their interdisciplinary projects.
As always Cort Johnson also provides a short version of his blogs, "The Gist"

“The strength of this research network is really everybody can learn from each other and utilize the different expertise that different groups, different labs have in this group.” Wengzhong Xiao Danielle Meadows, Vice President of the Open Medicine Foundation’s Research Programs and Operations...

12/03/2025

Yale's School of Medicine posted a short interview (also in audio) with Akiko Iwasaki, PhD, a professor that has been active in studying MECFS and Long Covid. Dr Iwasaki is asked: Do We Know What Causes Long Covid.

During an interview on the Health & Veritas podcast, Akiko Iwasaki, PhD, discussed post-acute infection syndromes, like Long COVID, and what we’re learning

11/25/2025

There is an increasing number of scientists that are collaborating with each other and their specific discoveries. Here is a quick 18 minute video interview with two of the scientists that are working to unravel the complexities of MECFS and Long Covid.

In an interview with Dr. Chris Armstrong and Dr. Wenzhong Xiao, two of OMF’s Directors, they talk about what they think is going on in ME/CFS, including diff...

11/15/2025

How is a weight loss medication helping people with ME/CFS and Long Covid? When Zepbound was studied there was evidence of other benefits beyond weight loss and it appears to be a strong anti-inflammatory drug also.

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.

11/04/2025

Science Daily reports on the newly discovered way to identify MECFS through DNA folds. Researchers state, "Our discovery offers the potential for a simple, accurate blood test to help confirm a diagnosis, which could lead to earlier support and more effective management."

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve faced doubt and misdiagnosis, it’s a breakthrough that finally validates their experience — an...

10/28/2025

The use of Oxaloacetate to treat "fatigue, cognitive function, and daily activity in people with ME/CFS, and what it reveals about how supporting cellular energy metabolism may help improve both brain and body function." This blog gives you the "Deep Dive" into this treatment and its benefits.

A new clinical trial led by researchers at the Bateman Horne Center (BHC) offers encouraging evidence that targeting metabolism may help improve both brain function and daily activity in people with…

10/21/2025

Fibromyalgia (FM) and MECFS are showing up in genetic studies as a similar genetic architecture. The authors stated that these findings are "putting FM on a “firm biological foundation”".
Cort Johnson of Health Rising provides his summary or "the gist" section if the article is too long or complicated to read.

Geoff’s Narration The GIST   Just months after the publication of the first large ME/CFS GWAS study comes an enormous FM GWAS study. Notice how these two diseases seem to be marching hand in hand. Both are greatly underfunded, both are still struggling for recognition in some circles, symptoms de...

10/09/2025

It is nice to read about what is happening in the world of ME/CFS research. This is a long technical report regarding promising research in finding a diagnostic biomarker.
Since this is long and technical you may want to read the abstract and then the conclusion to manage the information.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating, multifactorial disorder characterised by profound fatigue, post-exertional malaise, cognitive impairments, and autonomic dysfunction. Despite its significant impact on quality of life, ME/CFS lacks definitive diagnostic b...

10/02/2025

This is a webinar designed for healthcare providers and also all Long COVID and ME/CFS patient-lived experience experts interested in learning more about the treatment of Long COVID and ME/CFS.

"The aim of the webinar-style program is to rapidly disseminate post-acute Sequelae of COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome findings and emerging best practices".

Link is included in information to register for this free webinar sponsored by multiple medical groups.

08/26/2025

Tonmya has finally been approved for the treatment of fibromyalgia.

"For over 15 years, this community has been underserved and waiting for new treatment options. This approval is a promising step forward and brings renewed hope to millions.”

Tonmya is the first FDA approved drug for use in fibromyalgia in 15 years. Seth Lederman, CEO of Tonix Pharmaceuticals, talked about how the drug was developed, what it does, and when it will become available.

08/11/2025

A large study out of Edinburgh identifies a common genetic link in ME/CFS. Although genetics does not explain ME/CFS in its entirety it does add a possible puzzle piece to what causes ME/CFS and other post-infectious diseases.

Chronic fatigue syndrome or myalgic encephalomyelitis (ME/CFS) is a debilitating and long-neglected disease that experts typically dismissed as psychosomatic for decades.